These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 3096985)
1. Identification of the binding site for plasma prekallikrein in human high molecular weight kininogen. A region from residues 185 to 224 of the kininogen light chain retains full binding activity. Tait JF; Fujikawa K J Biol Chem; 1986 Nov; 261(33):15396-401. PubMed ID: 3096985 [TBL] [Abstract][Full Text] [Related]
2. Protein-protein interactions in contact activation of blood coagulation. Binding of high molecular weight kininogen and the 5-(iodoacetamido) fluorescein-labeled kininogen light chain to prekallikrein, kallikrein, and the separated kallikrein heavy and light chains. Bock PE; Shore JD; Tans G; Griffin JH J Biol Chem; 1985 Oct; 260(23):12434-43. PubMed ID: 3850090 [TBL] [Abstract][Full Text] [Related]
3. Interaction of factor XII, high-molecular-weight (HMW) kininogen and prekallikrein with sulfatide: analysis by fluorescence polarization. Shimada T; Kato H; Maeda H; Iwanaga S J Biochem; 1985 Jun; 97(6):1637-44. PubMed ID: 3928613 [TBL] [Abstract][Full Text] [Related]
4. Protein-protein interactions in contact activation of blood coagulation. Characterization of fluorescein-labeled human high molecular weight kininogen-light chain as a probe. Bock PE; Shore JD J Biol Chem; 1983 Dec; 258(24):15079-86. PubMed ID: 6558074 [TBL] [Abstract][Full Text] [Related]
5. Primary structure requirements for the binding of human high molecular weight kininogen to plasma prekallikrein and factor XI. Tait JF; Fujikawa K J Biol Chem; 1987 Aug; 262(24):11651-6. PubMed ID: 3650269 [TBL] [Abstract][Full Text] [Related]
6. Mapping of the high molecular weight kininogen binding site of prekallikrein. Evidence for a discontinuous epitope formed by distinct segments of the prekallikrein heavy chain. Herwald H; Jahnen-Dechent W; Alla SA; Hock J; Bouma BN; Müller-Esterl W J Biol Chem; 1993 Jul; 268(19):14527-35. PubMed ID: 7686159 [TBL] [Abstract][Full Text] [Related]
7. The role of bovine high-molecular-weight (HMW) kininogen in contact-mediated activation of bovine factor XII: interaction of HMW kininogen with kaolin and plasma prekallikrein. Ikari N; Sugo T; Fujii S; Kato H; Iwanaga S J Biochem; 1981 Jun; 89(6):1699-709. PubMed ID: 6912861 [TBL] [Abstract][Full Text] [Related]
8. Mapping of the discontinuous kininogen binding site of prekallikrein. A distal binding segment is located in the heavy chain domain A4. Herwald H; Renné T; Meijers JC; Chung DW; Page JD; Colman RW; Müller-Esterl W J Biol Chem; 1996 May; 271(22):13061-7. PubMed ID: 8662705 [TBL] [Abstract][Full Text] [Related]
9. Immunochemical studies of human high molecular weight kininogen and of its complexes with plasma prekallikrein or kallikrein. Kerbiriou DM; Bouma BN; Griffin JH J Biol Chem; 1980 May; 255(9):3952-8. PubMed ID: 6154706 [TBL] [Abstract][Full Text] [Related]
10. Localization of the binding site on plasma kallikrein for high-molecular-weight kininogen to both apple 1 and apple 4 domains of the heavy chain. Page JD; You JL; Harris RB; Colman RW Arch Biochem Biophys; 1994 Oct; 314(1):159-64. PubMed ID: 7944388 [TBL] [Abstract][Full Text] [Related]
11. Studies of binding of prekallikrein and Factor XI to high molecular weight kininogen and its light chain. Thompson RE; Mandle R; Kaplan AP Proc Natl Acad Sci U S A; 1979 Oct; 76(10):4862-6. PubMed ID: 291905 [TBL] [Abstract][Full Text] [Related]
12. Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein. Meier HL; Pierce JV; Colman RW; Kaplan AP J Clin Invest; 1977 Jul; 60(1):18-31. PubMed ID: 874082 [TBL] [Abstract][Full Text] [Related]
13. Function and immunochemistry of prekallikrein-high molecular weight kininogen complex in plasma. Scott CF; Colman RW J Clin Invest; 1980 Feb; 65(2):413-21. PubMed ID: 7356688 [TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibody to human high-molecular-weight kininogen recognizes its prekallikrein binding site and inhibits its coagulant activity. Reddigari SR; Kaplan AP Blood; 1989 Aug; 74(2):695-702. PubMed ID: 2752143 [TBL] [Abstract][Full Text] [Related]
15. Parallel mechanisms of high molecular weight kininogen action as a cofactor in kallikrein inactivation and prekallikrein activation reactions. Olson ST; Francis AM; Sheffer R; Choay J Biochemistry; 1993 Nov; 32(45):12148-59. PubMed ID: 8218292 [TBL] [Abstract][Full Text] [Related]
16. Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma. Mandle RJ; Colman RW; Kaplan AP Proc Natl Acad Sci U S A; 1976 Nov; 73(11):4179-83. PubMed ID: 1069308 [TBL] [Abstract][Full Text] [Related]
17. Isolation of a cationic fragment of high molecular mass kininogen and effect of this fragment on human plasma kallikrein activity. Yarovaya GA; Dotsenko VL; Orekhovich VN Clin Chim Acta; 1982 Aug; 123(3):261-7. PubMed ID: 6922013 [TBL] [Abstract][Full Text] [Related]
18. High molecular weight kininogen-binding site of prekallikrein probed by monoclonal antibodies. Hock J; Vogel R; Linke RP; Müller-Esterl W J Biol Chem; 1990 Jul; 265(20):12005-11. PubMed ID: 1694851 [TBL] [Abstract][Full Text] [Related]
19. Role of HMW kininogen in surface-mediated activation of Factor XII. Shimada T; Sugo T; Kato H; Iwanaga S Adv Exp Med Biol; 1983; 156():73-85. PubMed ID: 6134440 [TBL] [Abstract][Full Text] [Related]
20. Localization of distinct functional domains on prekallikrein for interaction with both high molecular weight kininogen and activated factor XII in a 28-kDa fragment (amino acids 141-371). Page JD; Colman RW J Biol Chem; 1991 May; 266(13):8143-8. PubMed ID: 1708772 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]